Media About Us


  • 07 March 2017

    New help for that bane of middle-age: blurry close-up vision

    New help for that bane of middle-age: blurry close-up vision

    Lauran Neergaad, AP Medical Writer / Associated Press

    Squinting while texting? Always losing your reading glasses? An eye implant that takes about 10 minutes to put in place is the newest in a list of surgical repairs for the blurry close-up vision that is a bane of middle age. But who's really a good candidate to toss their specs?

  • 16 February 2017

    Atlas to invest in extra capacity at STI test manufacturing partner Bespak

    Atlas to invest in extra capacity at STI test manufacturing partner Bespak

    Dani Bancroft / InPharma Technologist.com

    Atlas Genetics has said it will expand manufacturing capacity for cartridgebased STI tests at a UK facility owned by drug delivery technology firm Bespak Europe ltd.

  • 15 February 2017

    Liquid biopsies: The next frontier in cancer?

    Liquid biopsies: The next frontier in cancer?

    Ned Pagliarulo / BioPharmaDive

    As immuno-oncology dazzles and pharma companies race to develop new cancer medicines, a similar boom is underway to speed up and improve the detection of cancers.

  • 24 January 2017

    Struggling Marinus gets a bump out of a positive PhII snapshot

    Struggling Marinus gets a bump out of a positive PhII snapshot

    Arsalan Arif / Endpoints News

    A lit­tle more than six months since its stock price was crushed by a failed late-stage pro­gram for its lead­ing — and only — drug, tiny biotech mi­cro­cap Mar­i­nus $MRNS saw its shares shoot up this morn­ing after it of­fered a pos­i­tive Phase II snap­shot on a hand­ful of pa­tients who suf­fer from a rare ge­netic ail­ment.

  • 24 January 2017

    Marinus gets a lifeline with new ganaxolone data

    Marinus gets a lifeline with new ganaxolone data

    Ben Adams / Fierce Biotech

    Micro cap Marinus Pharmaceuticals was up 28% premarket this morning on positive, early data from its midstage test of ganaxolone in a rare condition that causes severe seizures.

  • 11 January 2017

    JP Morgan Healthcare Conference, Day One: Genomic Health, Meridian Bioscience, Qiagen

    JP Morgan Healthcare Conference, Day One: Genomic Health, Meridian Bioscience, Qiagen

    Ed Winnick / GenomeWeb

    The 35th Annual JP Morgan Healthcare Conference began here Monday with several life science research tools and diagnostic firms making presentations to investors and other attendees.

  • 09 January 2017

    Epic uncovers prostate cancer biomarker

    Epic uncovers prostate cancer biomarker

    Lori Lesko / DDNEWS Cancer Research News

    Biotech company Epic Sciences’ focus on circulating tumor cells (CTCs) will not only advance the clinical use of liquid biopsies and improve how metastatic cancer is treated, it says, but also identified a unique CTC biomarker in patients with metastatic prostate cancer who respond to PARP inhibitors cancer drugs in development.

  • 05 January 2017

    Raindrop Vision Procedure Designed to Reduce or Eliminate Reading Glasses Now Available in Alabama.

    Raindrop Vision Procedure Designed to Reduce or Eliminate Reading Glasses Now Available in Alabama.

    PRWeb

    The All-New Raindrop® Near Vision Inlay is designed to improve near vision so you can once again see fine print, menus and your phone without the hassle of reading glasses.

  • 28 December 2016

    Pfizer and NovaMedica complete strategic partnership

    Pfizer and NovaMedica complete strategic partnership

    The Pharma Letter

    US pharma giant Pfizer (NYSE: PFE) and Russia’s NovaMedica, a company established in 2012 by Russian high-technology investment fund Rusnano and American healthcare fund Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio.

  • 19 December 2016

    US-Russia Relations: Why Donald Trump is Right to Look East

    US-Russia Relations: Why Donald Trump is Right to Look East

    David Morgan / Global Research

    ​US President-elect Donald J Trump has been widely criticised by his liberal critics in the media and by Democratic Party opponents for wanting to normalise his country’s relations with Russia and to adopt a more balanced approach towards Moscow.